[go: up one dir, main page]

AU3733293A - Method and agents for promoting wound healing - Google Patents

Method and agents for promoting wound healing

Info

Publication number
AU3733293A
AU3733293A AU37332/93A AU3733293A AU3733293A AU 3733293 A AU3733293 A AU 3733293A AU 37332/93 A AU37332/93 A AU 37332/93A AU 3733293 A AU3733293 A AU 3733293A AU 3733293 A AU3733293 A AU 3733293A
Authority
AU
Australia
Prior art keywords
agents
wound healing
promoting wound
promoting
healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37332/93A
Inventor
Anthony Cerami
Veronica M. Ruszala-Mallon
Michael A. Yamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Synvista Therapeutics Inc
Original Assignee
Rockefeller University
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University, Alteon Inc filed Critical Rockefeller University
Publication of AU3733293A publication Critical patent/AU3733293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU37332/93A 1992-02-25 1993-02-25 Method and agents for promoting wound healing Abandoned AU3733293A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US841383 1986-03-04
US84138392A 1992-02-25 1992-02-25

Publications (1)

Publication Number Publication Date
AU3733293A true AU3733293A (en) 1993-09-13

Family

ID=25284734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37332/93A Abandoned AU3733293A (en) 1992-02-25 1993-02-25 Method and agents for promoting wound healing

Country Status (2)

Country Link
AU (1) AU3733293A (en)
WO (1) WO1993016717A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5837682A (en) 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5854221A (en) * 1996-12-12 1998-12-29 The Children's Medical Center Corporation Endothelial cell proliferation inhibitor and method of use
AU6349501A (en) 2000-05-31 2001-12-11 Encelle Inc Method of treating chronic ulcers
DE10160966A1 (en) * 2001-12-12 2003-06-26 Beiersdorf Ag Melanin-forming hair coloring product
DE102008059765A1 (en) * 2008-12-01 2010-06-02 Henkel Ag & Co. Kgaa New deodorants and antiperspirants with hair growth inhibiting effect

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0157359A2 (en) * 1984-04-02 1985-10-09 National Jewish Hospital and Research Center Collagen matrix for tissue repair
AU600306B2 (en) * 1986-09-12 1990-08-09 Rockefeller University, The Methods and agents for removing advanced glycosylation endproducts
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
WO1993004086A1 (en) * 1991-08-23 1993-03-04 The Rockefeller University Receptors for advanced glycosylation endproducts and uses thereof

Also Published As

Publication number Publication date
WO1993016717A1 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
AU2502395A (en) Battery-actuated insecticide transpirator and method for transpirating insecticide
AU4985993A (en) Toothbrush and method for making such toothbrush
AU667552B2 (en) Reprogramming methods and apparatus
AU1875692A (en) Exhaust treatment system and method
AU7516194A (en) Wound treatment
AU6515794A (en) Cornea operating method and apparatus
AU5237093A (en) Attachment apparatus and method
AU5451494A (en) Micro-hotplate devices and methods for their fabrication
AU2358197A (en) Implantable access devices and method
AU3201093A (en) Dental composition and method
AU6847894A (en) Method for the improvement of wound healing and compositions therefor
GB9206492D0 (en) Wound healing composition
AU4489693A (en) Apparatus and methods for improved construction
AU3975993A (en) Method and composition for treating acne
AU2143692A (en) Assembly and method for applying hemostatic agents
AU3127795A (en) Composition and treatment for baldness
AU3733293A (en) Method and agents for promoting wound healing
AU4220193A (en) Deazaaminopterins for treatment of inflammation
HK1007624B (en) Coil form and method for its use
AU3720293A (en) Method and compositions for treating acne
AU2719088A (en) Wound healing composition and method
AU5149793A (en) Method of preparing aminoalkylhydantoins and aminoalkyl-alpha-aminoacids
AU661596B2 (en) Veterinary method
AU5466694A (en) Method and device for effecting aesthesiometries
AU2966695A (en) Method and compound for the treatment of hair loss